Referências
Principais artigos
Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. Resumo
Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-28.Texto completo Resumo
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95.Texto completo Resumo
Artigos de referência
1. Wolfe F, Walitt B, Rasker JJ, et al. Primary and secondary fibromyalgia are the same: the universality of polysymptomatic distress. J Rheumatol. 2019 Feb;46(2):204-12.Texto completo Resumo
2. Castro-Sánchez AM, Matarán-Peñarrocha GA, López-Rodríguez MM, et al. Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012 Dec;13(12):1639-47.Texto completo Resumo
3. Miró E, Diener FN, Martínez MP, et al. Fibromyalgia in men and women: comparison of the main clinical symptoms. Psicothema. 2012 Feb;24(1):10-5. Resumo
4. Wolfe F, Walitt B, Perrot S, et al. Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS One. 2018;13(9):e0203755.Texto completo Resumo
5. Conversano C, Ciacchini R, Orrù G, et al. Gender differences on psychological factors in fibromyalgia: a systematic review on the male experience. Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):174-85.Texto completo Resumo
6. Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med. 2002 Mar-Apr;5(2):42-7. Resumo
7. Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013 May;65(5):786-92. Resumo
8. Jones GT, Atzeni F, Beasley M, et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015 Feb;67(2):568-75.Texto completo Resumo
9. Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol. 2005 Mar-Apr;34(2):140-4. Resumo
10. Haq SA, Darmawan J, Islam MN, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005 Feb;32(2):348-53. Resumo
11. White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001 Aug;5(4):320-9. Resumo
12. Wolfe F. The epidemiology of fibromyalgia. J Musculoskel Pain. 1993;1:137.
13. Raspe H, Baumgartner C, Wolfe F. The prevalence of fibromyalgia in a rural German community: how much difference do criteria make? Arthritis Rheum. 1993;36(9 Suppl):S48.
14. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22.Texto completo Resumo
15. Marques AP, Espírito Santo AS, Berssaneti AA, et al. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017 Jul-Aug;57(4):356-63.Texto completo Resumo
16. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004 Mar;50(3):944-52.Texto completo Resumo
17. Hudson JI, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry. 1985 Apr;142(4):441-6. Resumo
18. Mogil JS, Yu L, Basbaum AI. Pain genes?: natural variation and transgenic mutants. Annu Rev Neurosci. 2000 Mar;23:777-811. Resumo
19. Diatchenko L, Nackley AG, Tchivileva IE, et al. Genetic architecture of human pain perception. Trends Genet. 2007 Dec;23(12):605-13. Resumo
20. Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006 Nov;12(11):1269-77. Resumo
21. Kleykamp BA, Ferguson MC, McNicol E, et al. The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum. 2021 Feb;51(1):166-74.Texto completo Resumo
22. Kato K, Sullivan PF, Evengard B, et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med. 2006 Aug 14-28;166(15):1649-54. Resumo
23. Kato K, Sullivan PF, Evengard B, et al. A population-based twin study of functional somatic syndromes. Psychol Med. 2009 Mar;39(3):497-505. Resumo
24. Markkula R, Järvinen P, Leino-Arjas P, et al. Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain. 2009 Aug;13(7):744-50. Resumo
25. Balagué F, Nordin M. Back pain in children and teenagers. Baillieres Clin Rheumatol. 1992 Oct;6(3):575-93. Resumo
26. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569-80. Resumo
27. Aaron LA, Bradley LA, Alarcón GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996 Mar;39(3):436-45. Resumo
28. Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am. 2009 May;35(2):263-74.Texto completo Resumo
29. O'Brien AT, Deitos A, Triñanes Pego Y, et al. Defective endogenous pain modulation in fibromyalgia: a meta-analysis of temporal summation and conditioned pain modulation paradigms. J Pain. 2018 Aug;19(8):819-36.Texto completo Resumo
30. Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain. 2009 Jul;144(1-2):95-100. Resumo
31. Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005 Mar;114(1-2):295-302. Resumo
32. Montoya P, Sitges C, García-Herrera M, et al. Reduced brain habituation to somatosensory stimulation in patients with fibromyalgia. Arthritis Rheum. 2006 Jun;54(6):1995-2003.Texto completo Resumo
33. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994 Nov;37(11):1593-601.Texto completo Resumo
34. Haas L, Portela LV, Böhmer AE, et al. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010 May;35(5):830-4. Resumo
35. Staud R, Godfrey MM, Robinson ME. Fibromyalgia patients are not only hypersensitive to painful stimuli but also to acoustic stimuli. J Pain. 2021 Aug;22(8):914-25.Texto completo Resumo
36. Hubbard CS, Lazaridou A, Cahalan CM, et al. Aberrant salience? Brain hyperactivation in response to pain onset and offset in fibromyalgia. Arthritis Rheumatol. 2020 Jul;72(7):1203-13. Resumo
37. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005 May;52(5):1577-84.Texto completo Resumo
38. Kim J, Loggia ML, Cahalan CM, et al. The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction. Arthritis Rheumatol. 2015 May;67(5):1395-405.Texto completo Resumo
39. Loggia ML, Berna C, Kim J, et al. Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol. 2014 Jan;66(1):203-12.Texto completo Resumo
40. Kamping S, Bomba IC, Kanske P, et al. Deficient modulation of pain by a positive emotional context in fibromyalgia patients. Pain. 2013 Sep;154(9):1846-55. Resumo
41. Balducci T, Garza-Villarreal EA, Valencia A, et al. Abnormal functional neurocircuitry underpinning emotional processing in fibromyalgia. Eur Arch Psychiatry Clin Neurosci. 2023 Mar 24.Texto completo Resumo
42. Roizenblatt S, Neto NS, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):347-57. Resumo
43. Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheum Dis Clin North Am. 2009 May;35(2):275-83. Resumo
44. Fang SC, Wu YL, Chen SC, et al. Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia. J Sleep Res. 2019 Dec;28(6):e12843. Resumo
45. Celepkolu T, Gamze Erten Bucaktepe P, Yilmaz A, et al. Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses. Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4506-13.Texto completo Resumo
46. Roehrs T, Diederichs C, Gillis M, et al. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med. 2013 Jan;14(1):109-15.Texto completo Resumo
47. Yeung WK, Morgan K, Mckenna F. Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls. J Sleep Res. 2018 Apr;27(2):290-8. Resumo
48. Mork PJ, Nilsen TI. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012 Jan;64(1):281-4.Texto completo Resumo
49. Pednekar DD, Amin MR, Azgomi HF, et al. A system theoretic investigation of cortisol dysregulation in fibromyalgia patients with chronic fatigue. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:6896-6901. Resumo
50. Pednekar DD, Amin MR, Azgomi HF, et al. Characterization of cortisol dysregulation in fibromyalgia and chronic fatigue syndromes: a state-space approach. IEEE Trans Biomed Eng. 2020 Nov;67(11):3163-72.Texto completo Resumo
51. Úbeda-D'Ocasar E, Jiménez Díaz-Benito V, Gallego-Sendarrubias GM, et al. Pain and Cortisol in Patients with Fibromyalgia: Systematic Review and Meta-Analysis. Diagnostics (Basel). 2020 Nov 9;10(11):922.Texto completo Resumo
52. Adler GK, Kinsley BT, Hurwitz S, et al. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999 May;106(5):534-43. Resumo
53. McLean SA, Williams DA, Harris RE, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3660-9.Texto completo Resumo
54. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum. 2007 Jan;56(1):360-71.Texto completo Resumo
55. Riva R, Mork PJ, Westgaard RH, et al. Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res. 2012 Jan;72(1):51-7.Texto completo Resumo
56. Kadetoff D, Kosek E. Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehabil Med. 2010 Sep;42(8):765-72.Texto completo Resumo
57. Parati G, Mancia G, Di Rienzo M, et al. Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985). 2006 Aug;101(2):676-8; discussion 681-2.Texto completo Resumo
58. Lerma C, Martinez A, Ruiz N, et al. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther. 2011;13(6):R185.Texto completo Resumo
59. Vreijling SR, Troudart Y, Brosschot JF.Reduced heart rate variability in patients with medically Uunexplained physical symptoms: a meta-analysis of HF-HRV and RMSSD. Psychosom Med. 2021 Jan;83(1):2-15. Resumo
60. Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008 Feb;47(2):208-11.Texto completo Resumo
61. Kim SH, Kim DH, Oh DH, et al. Characteristic electron microscopic findings in the skin of patients with fibromyalgia - preliminary study. Clin Rheumatol. 2008 Mar;27(3):407-11. Resumo
62. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009 Jun;65(6):629-38. Resumo
63. Grayston R, Czanner G, Elhadd K, et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum. 2019 Apr;48(5):933-40.Texto completo Resumo
64. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004 Nov 17;24(46):10410-5.Texto completo Resumo
65. Sundgren PC, Petrou M, Harris RE, et al. Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: a prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity. Acad Radiol. 2007 Jul;14(7):839-46. Resumo
66. Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci. 2007 Apr 11;27(15):4004-7.Texto completo Resumo
67. Luerding R, Weigand T, Bogdahn U, et al. Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain. 2008 Dec;131(Pt 12):3222-31.Texto completo Resumo
68. Lutz J, Jäger L, de Quervain D, et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 2008 Dec;58(12):3960-9.Texto completo Resumo
69. Schmidt-Wilcke T. Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep. 2008 Dec;10(6):467-74. Resumo
70. Hsu MC, Harris RE, Sundgren PC, et al. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain. 2009 Jun;143(3):262-7. Resumo
71. Coskun Benlidayi I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int. 2019 May;39(5):781-91.Texto completo Resumo
72. Banfi G, Diani M, Pigatto PD, et al. T cell subpopulations in the physiopathology of fibromyalgia: evidence and perspectives. Int J Mol Sci. 2020 Feb 11;21(4):1186.Texto completo Resumo
73. Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016 Dec 3;338:114-29.Texto completo Resumo
74. Stormorken H, Brosstad F. Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a "true" disease. Scand J Rheumatol. 1992;21(4):207. Resumo
75. Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil. 1989 Jan;70(1):61-3. Resumo
76. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics. 2007 Jan;8(1):67-74. Resumo
77. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia: genetic aspects of fibromyalgia syndrome. Arthritis Res Ther. 2007 Jan;8(1):67-74.Texto completo Resumo
78. Limer KL, Nicholl BI, Thomson W, et al. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology (Oxford). 2008 May;47(5):572-7.Texto completo Resumo
79. Martínez-Jauand M, Sitges C, Rodríguez V, et al. Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain. 2013 Jan;17(1):16-27. Resumo
80. Nicholl BI, Holliday KL, Macfarlane GJ, et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. Arthritis Rheum. 2011 Mar;63(3):810-8.Texto completo Resumo
81. Estévez-López F, Guerrero-González JM, Salazar-Tortosa D, et al. Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project. Rheumatology (Oxford). 2022 Aug 3;61(8):3180-91.Texto completo Resumo
82. Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019 Jun;33(3):101423.Texto completo Resumo
83. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states - maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):141-54. Resumo
84. Kaleycheva N, Cullen AE, Evans R, et al. The role of lifetime stressors in adult fibromyalgia: systematic review and meta-analysis of case-control studies. Psychol Med. 2021 Jan;51(2):177-93.Texto completo Resumo
85. Oliveira ÍMX, Silva RDSUD. Rheumatological manifestations associated with viral hepatitis B or C. Rev Soc Bras Med Trop. 2019;52:e20180407.Texto completo Resumo
86. Ablin JN, Shoenfeld Y, Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun. 2006 Nov;27(3):145-52.Texto completo Resumo
87. Cassisi G, Sarzi-Puttini P, Cazzola M. Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol. 2011 Nov-Dec;29(6 suppl 69):S118-26. Resumo
88. Ursini F, Ciaffi J, Mancarella L, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 Aug;7(3):e001735.Texto completo Resumo
89. Savin E, Rosenn G, Tsur AM, et al. The possible onset of fibromyalgia following acute COVID-19 infection. PLoS One. 2023;18(2):e0281593.Texto completo Resumo
90. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001 Nov;28(11):2535-9.Texto completo Resumo
91. McCabe PS, Pye SR, Beth JM, et al. Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study. BMC Musculoskelet Disord. 2016 Jan 16;17:32.Texto completo Resumo
92. Bhatty SA, Shaikh NA, Irfan M, et al. Vitamin D deficiency in fibromyalgia. J Pak Med Assoc. 2010 Nov;60(11):949-51. Resumo
93. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003 Dec;78(12):1463-70. Resumo
94. Martins YA, Cardinali CAEF, Ravanelli MI, et al. Is hypovitaminosis D associated with fibromyalgia? A systematic review. Nutr Rev. 2020 Feb;78(2):115-33.Texto completo Resumo
95. Goldenberg DL. Diagnosing fibromyalgia as a disease, an illness, a state, or a trait? Arthritis Care Res (Hoboken). 2019 Mar;71(3):334-6.Texto completo Resumo
96. Arnold LM, Bennett RM, Crofford LJ, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019 Jun;20(6):611-28.Texto completo Resumo
97. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. Resumo
98. Wu YL, Chang LY, Lee HC, et al. Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res. 2017 May;96:89-97.Texto completo Resumo
99. Marvisi M, Balzarini L, Mancini C, et al. Fibromyalgia is frequent in obstructive sleep apnea and responds to CPAP therapy. Eur J Intern Med. 2015 Nov;26(9):e49-50. Resumo
100. Terzi R, Yılmaz Z. Evaluation of pain sensitivity by tender point counts and myalgic score in patients with and without obstructive sleep apnea syndrome. Int J Rheum Dis. 2017 Mar;20(3):340-5.Texto completo Resumo
101. Mutlu P, Zateri C, Zohra A, et al. Prevalence of obstructive sleep apnea in female patients with fibromyalgia. Saudi Med J. 2020 Jul;41(7):740-5.Texto completo Resumo
102. Altıntop Geçkil A, Aydoğan Baykara R. Coexistence of obstructive sleep apnea syndrome and fibromyalgia. Tuberk Toraks. 2022 Mar;70(1):37-43. Resumo
103. Torta RG, Tesio V, Ieraci V, et al. Fibro-fog. Clin Exp Rheumatol. 2016 Mar-Apr;34(2 suppl 96):S6-8. Resumo
104. Bell T, Trost Z, Buelow MT, et al. Meta-analysis of cognitive performance in fibromyalgia. J Clin Exp Neuropsychol. 2018 Sep;40(7):698-714.Texto completo Resumo
105. Wu YL, Huang CJ, Fang SC, et al. Cognitive impairment in fibromyalgia: a meta-analysis of case-control studies. Psychosom Med. 2018 Jun;80(5):432-8. Resumo
106. Dadabhoy D, Crofford LJ, Spaeth M, et al. Biology and therapy of fibromyalgia: evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther. 2008 Aug 8;10(4):211.Texto completo Resumo
107. Berwick RJ, Siew S, Andersson DA, et al. A systematic review into the influence of temperature on fibromyalgia pain: meteorological studies and quantitative sensory testing. J Pain. 2021 May;22(5):473-86.Texto completo Resumo
108. Ten Brink AF, Bultitude JH. Visual sensitivity in complex regional pain syndrome and fibromyalgia: an online study. Perception. 2022 Mar;51(3):187-209.Texto completo Resumo
109. Ayouni I, Chebbi R, Hela Z, et al. Comorbidity between fibromyalgia and temporomandibular disorders: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jul;128(1):33-42. Resumo
110. Besiroglu MDH, Dursun MDM. The association between fibromyalgia and female sexual dysfunction: a systematic review and meta-analysis of observational studies. Int J Impot Res. 2019 Jul;31(4):288-97. Resumo
111. Ricoy-Cano AJ, Cortés-Pérez I, Del Carmen Martín-Cano M, et al. Impact of fibromyalgia syndrome on female sexual function: a systematic review with meta-analysis. J Clin Rheumatol. 2022 Mar 1;28(2):e574-82. Resumo
112. Thornton KGS, Robert M. Prevalence of pelvic floor disorders in the fibromyalgia population: a systematic review. J Obstet Gynaecol Can. 2020 Jan;42(1):72-9. Resumo
113. Sumpton JE, Moulin DE. Fibromyalgia. Handb Clin Neurol. 2014;119:513-27.Texto completo Resumo
114. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014 Sep;13(9):924-35. Resumo
115. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.Texto completo Resumo
116. Arora N, Gupta A, Reddy SB. Antinuclear antibody and subserology testing in the evaluation of fibromyalgia: a teachable moment. JAMA Intern Med. 2017 Sep;177(9):1369-70. Resumo
117. Bossema ER, van Middendorp H, Jacobs JW, et al. Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1019-25.Texto completo Resumo
118. de Tommaso M, Federici A, Serpino C, et al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011 Dec;12(6):629-38.Texto completo Resumo
119. Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003 Oct;48(10):2916-22.Texto completo Resumo
120. Komaroff AL. Myalgic encephalomyelitis/chronic fatigue syndrome: a real illness. Ann Intern Med. 2015 Jun;162(12):871-2.Texto completo Resumo
121. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10.Texto completo Resumo
122. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-28.Texto completo Resumo
123. Migliorini F, Maffulli N, Eschweiler J, et al. BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromyalgia: a systematic review. Expert Rev Clin Pharmacol. 2021 Aug;14(8):1029-1038.Texto completo Resumo
124. Bennett RM, Friend R, Jones KD, et al. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.Texto completo Resumo
125. Salaffi F, Di Carlo M, Arcà S, et al. Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy. Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1074-1081.Texto completo Resumo
126. Hernando-Garijo I, Jiménez-Del-Barrio S, Mingo-Gómez T, et al. Effectiveness of non-pharmacological conservative therapies in adults with fibromyalgia: a systematic review of high-quality clinical trials. J Back Musculoskelet Rehabil. 2022;35(1):3-20.Texto completo Resumo
127. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95.Texto completo Resumo
128. Geraghty AWA, Maund E, Newell D, et al. Self-management for chronic widespread pain including fibromyalgia: A systematic review and meta-analysis. PLoS One. 2021;16(7):e0254642.Texto completo Resumo
129. García-Ríos MC, Navarro-Ledesma S, Tapia-Haro RM, et al. Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2019 Apr;55(2):301-313. Resumo
130. Musekamp G, Gerlich C, Ehlebracht-Kï Nig I, et al. Evaluation of a self-management patient education programme for fibromyalgia-results of a cluster-RCT in inpatient rehabilitation. Health Educ Res. 2019 Apr 1;34(2):209-22. Resumo
131. Kim CH, Luedtke CA, Vincent A, et al. Association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2012 Feb;64(2):222-8.Texto completo Resumo
132. Atzeni F, Alciati A, Salaffi F, et al. The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients. Rheumatol Adv Pract. 2021;5(1):rkab015.Texto completo Resumo
133. D'Onghia M, Ciaffi J, Lisi L, et al. Fibromyalgia and obesity: a comprehensive systematic review and meta-analysis. Semin Arthritis Rheum. 2021 Apr;51(2):409-24.Texto completo Resumo
134. Busch AJ, Webber SC, Richards RS, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013 Dec 20;2013(12):CD010884.Texto completo Resumo
135. Bidonde J, Busch AJ, Schachter CL, et al. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2019 May 24;(5):CD013340.Texto completo Resumo
136. Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010 Aug 19;363(8):743-54.Texto completo Resumo
137. Barker AL, Talevski J, Morello RT, et al. Effectiveness of aquatic exercise for musculoskeletal conditions: a meta-analysis. Arch Phys Med Rehabil. 2014 Sep;95(9):1776-86. Resumo
138. Estévez-López F, Maestre-Cascales C, Russell D, et al. Effectiveness of exercise on fatigue and sleep quality in fibromyalgia: a systematic review and meta-analysis of randomized trials. Arch Phys Med Rehabil. 2021 Apr;102(4):752-61.Texto completo Resumo
139. Cheng CA, Chiu YW, Wu D, et al. Effectiveness of Tai Chi on fibromyalgia patients: a meta-analysis of randomized controlled trials. Complement Ther Med. 2019 Oct;46:1-8.Texto completo Resumo
140. Bravo C, Skjaerven LH, Guitard Sein-Echaluce L, et al. Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2019 Oct;55(5):646-57. Resumo
141. Andrade A, de Azevedo Klumb Steffens R, Sieczkowska SM, et al. A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations. Adv Rheumatol. 2018 Oct 22;58(1):36. Resumo
142. Vilarino GT, Andreato LV, de Souza LC, et al. Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review. Clin Rheumatol. 2021 Nov;40(11):4417-25. Resumo
143. Bidonde J, Busch AJ, Schachter CL, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017 Jun;6(6):CD012700.Texto completo Resumo
144. Ferro Moura Franco K, Lenoir D, Dos Santos Franco YR, et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: a systematic review with meta-analysis. Eur J Pain. 2021 Jan;25(1):51-70.Texto completo Resumo
145. Williams ACC, Fisher E, Hearn L, et al. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007407.Texto completo Resumo
146. Samami E, Shahhosseini Z, Elyasi F. The effect of psychological interventions on the quality of life in women with fibromyalgia: a systematic review. J Clin Psychol Med Settings. 2021 Sep;28(3):503-17. Resumo
147. Williams DA, Kuper D, Segar M, et al. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain. 2010 Dec;151(3):694-702. Resumo
148. Nüesch E, Häuser W, Bernardy K, et al. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013 Jun;72(6):955-62. Resumo
149. Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996 Nov;39(11):1852-9. Resumo
150. Mease PJ, Farmer MV, Palmer RH, et al. Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin. Ther Adv Musculoskelet Dis. 2013 Jun;5(3):113-26.Texto completo Resumo
151. Gilron I, Chaparro LE, Tu D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016 Jul;157(7):1532-40. Resumo
152. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000 Mar-Apr;41(2):104-13. Resumo
153. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004 Feb 15;51(1):9-13.Texto completo Resumo
154. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants. J Gen Intern Med. 2000 Sep;15(9):659-66.Texto completo Resumo
155. Nishishinya B, Urrútia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford). 2008 Dec;47(12):1741-6.Texto completo Resumo
156. Welsch P, Üçeyler N, Klose P, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018 Feb 28;(2):CD010292.Texto completo Resumo
157. Lian YN, Wang Y, Zhang Y, et al. Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis. Int J Neurosci. 2020 Jan;130(1):71-82.Texto completo Resumo
158. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005 Oct;32(10):1975-85. Resumo
159. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009 Feb;36(2):398-409. Resumo
160. Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008 Nov;30(11):1988-2004. Resumo
161. Kyle JA, Dugan BD, Testerman KK. Milnacipran for treatment of fibromyalgia. Ann Pharmacother. 2010 Sep;44(9):1422-9. Resumo
162. Arnold LM, Gendreau RM, Palmer RH, et al. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010 Sep;62(9):2745-56. Resumo
163. de Farias ÁD, Eberle L, Amador TA, et al. Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Adv Rheumatol. 2020 Jul 8;60(1):35. Resumo
164. Mease PJ, Russell IJ, Kajdasz DK, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010 Jun;39(6):454-64. Resumo
165. Branco JC, Zachrisson O, Perrot S, et al. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010 Apr;37(4):851-9. Resumo
166. Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010 May 1;33(5):393-407. Resumo
167. Choy EH, Mease PJ, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009 Sep;28(9):1035-44.Texto completo Resumo
168. Arnold LM, Choy E, Clauw DJ, et al. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin. 2018 Aug;34(8):1397-409. Resumo
169. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007 Apr;56(4):1336-44.Texto completo Resumo
170. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005 Apr;52(4):1264-73.Texto completo Resumo
171. Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016 Sep 29;(9):CD011790.Texto completo Resumo
172. Häuser W, Bernardy K, Uçeyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials. Pain. 2009 Sep;145(1-2):69-81. Resumo
173. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014 Apr 16;311(15):1547-55. Resumo
174. Derry S, Wiffen PJ, Häuser W, et al. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Mar 27;(3):CD012332.Texto completo Resumo
175. Gaskell H, Moore RA, Derry S, et al. Oxycodone for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016 Sep 1;(9):CD012329.Texto completo Resumo
176. da Rocha AP, Mizzaci CC, Nunes Pinto AC, et al. Tramadol for management of fibromyalgia pain and symptoms: systematic review. Int J Clin Pract. 2020 Mar;74(3):e13455. Resumo
177. Mhalla A, Baudic S, Ciampi de Andrade D, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain. 2011 Jul;152(7):1478-85. Resumo
178. O'Connell NE, Marston L, Spencer S, et al. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2018 Apr 13;(4):CD008208.Texto completo Resumo
179. Fagerlund AJ, Hansen OA, Aslaksen PM. Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain. 2015 Jan;156(1):62-71. Resumo
180. Fregni F, El-Hagrassy MM, Pacheco-Barrios K, et al. Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders. Int J Neuropsychopharmacol. 2021 Apr;24(4):256-313.Texto completo Resumo
181. Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528.Texto completo Resumo
182. Lloyd DM, Wittkopf PG, Arendsen LJ, et al. Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis. J Pain. 2020 Nov-Dec;21(11-12):1085-100.Texto completo Resumo
183. Hatfield E, Phillips K, Swidan S, et al. Use of low-dose naltrexone in the management of chronic pain conditions: a systematic review. J Am Dent Assoc. 2020 Dec;151(12):891-902.e1. Resumo
184. Younger J, Noor N, McCue R, et al. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013 Feb;65(2):529-38.Texto completo Resumo
185. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov;72(5):735-44.Texto completo Resumo
186. Walitt B, Klose P, Fitzcharles MA, et al. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016 Jul 18;(7):CD011694.Texto completo Resumo
187. Fitzcharles MA, Niaki OZ, Hauser W, et al. Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases. J Rheumatol. 2019 May;46(5):532-8.Texto completo Resumo
188. Berger AA, Keefe J, Winnick A, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):617-31. Resumo
189. Guillouard M, Authier N, Pereira B, et al. Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). 2021 Feb;60(2):549-56.Texto completo Resumo
190. Cohen SP, Verdolin MH, Chang AS, et al. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain. 2006 Jun;7(6):391-8. Resumo
191. Kurian R, Raza K, Shanthanna H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain. 2019 Aug;23(7):1234-50.Texto completo Resumo
192. Arnold LM, Chatamra K, Hirsch I, et al. Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2010 Aug;32(9):1618-32. Resumo
193. Welsch P, Bernardy K, Derry S, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev. 2018 Aug;8(8):CD012708.Texto completo Resumo
194. Hemati K, Amini Kadijani A, Sayehmiri F, et al. Melatonin in the treatment of fibromyalgia symptoms: a systematic review. Complement Ther Clin Pract. 2020 Feb;38:101072.Texto completo Resumo
195. Johnson MI, Claydon LS, Herbison GP, et al. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Oct 9;(10):CD012172.Texto completo Resumo
196. Dailey DL, Vance CGT, Rakel BA, et al. Transcutaneous electrical nerve stimulation reduces movement-evoked pain and fatigue: a randomized, controlled trial. Arthritis Rheumatol. 2020 May;72(5):824-36.Texto completo Resumo
197. Lange G, Janal MN, Maniker A, et al. Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial. Pain Med. 2011 Sep;12(9):1406-13.Texto completo Resumo
198. Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010 Apr;16(4):397-409. Resumo
199. Sarmiento-Hernández I, Pérez-Marín MLÁ, Nunez-Nagy S, et al. Effectiveness of invasive techniques in patients with fibromyalgia: systematic review and meta-analysis. Pain Med. 2020 Dec;21(12):3499-511.Texto completo Resumo
200. Deare JC, Zheng Z, Xue CC, et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013 May;2013(5):CD007070.Texto completo Resumo
201. Radvanski DC, Vaschillo EG, Vaschillo B, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. App Psychophys Biofeedback. 2007 Mar;32(1):1-10. Resumo
202. Babu AS, Mathew E, Danda D, et al. Management of patients with fibromyalgia using biofeedback: a randomized control trial. Indian J Med Sci. 2007 Aug;61(8):455-61. Resumo
203. Porter NS, Jason LA, Boulton A, et al. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010 Mar;16(3):235-49. Resumo
204. Ferreira I, Ortigoza Á, Moore P. Magnesium and malic acid supplement for fibromyalgia. [in spa]. Medwave. 2019 May;19(4):e7633. Resumo
205. Mehrabani S, Askari G, Miraghajani M, et al. Effect of coenzyme Q10 supplementation on fatigue: a systematic review of interventional studies. Complement Ther Med. 2019 Apr;43:181-7.Texto completo Resumo
206. Perry R, Terry R, Ernst E. A systematic review of homoeopathy for the treatment of fibromyalgia. Clin Rheumatol. 2010 May;29(5):457-64. Resumo
207. Langhorst J, Musial F, Klose P, et al. Efficacy of hydrotherapy in fibromyalgia syndrome - a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2009 Sep;48(9):1155-9. Resumo
208. Antonelli M, Donelli D, Veronesi L, et al. Clinical efficacy of medical hydrology: an umbrella review. Int J Biometeorol. 2021 Oct;65(10):1597-1614. Resumo
209. Schneider M, Vernon H, Ko G, et al. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009 Jan;32(1):25-40. Resumo
210. Bronfort GH, Haas M, Evans R, et al. Effectiveness of manual therapies: the UK evidence report. Chiroprac Osteopat. 2010 Feb 25;18:3.Texto completo Resumo
211. Kalichman L. Massage therapy for fibromyalgia symptoms. Rheumatol Int. 2010 Jul;30(9):1151-7. Resumo
212. Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol. 2009 Oct;28(10):1175-8. Resumo
213. Chen KW, Hassett AL, Hou F, et al. A pilot study of external qigong therapy for patients with fibromyalgia. J Altern Complement Med. 2006 Nov;12(9):851-6. Resumo
214. D'Onghia M, Ciaffi J, McVeigh JG, et al. Fibromyalgia syndrome - a risk factor for poor outcomes following orthopaedic surgery: a systematic review. Semin Arthritis Rheum. 2021 Aug;51(4):793-803.Texto completo Resumo
215. Dreyer L, Kendall S, Danneskiold-Samsøe B, et al. Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum. 2010 Oct;62(10):3101-8.Texto completo Resumo
216. McKernan LC, Lenert MC, Crofford LJ, et al. Outpatient engagement and predicted risk of suicide attempts in fibromyalgia. Arthritis Care Res (Hoboken). 2019 Sep;71(9):1255-63.Texto completo Resumo
217. Gill H, Perez CD, Gill B, et al. The prevalence of suicidal behaviour in fibromyalgia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110078.Texto completo Resumo
218. Basavakumar D, Flegg M, Eccles J, et al. Accuracy, completeness and accessibility of online information on fibromyalgia. Rheumatol Int. 2019 Apr;39(4):735-42.Texto completo Resumo
219. Ozsoy-Unubol T, Alanbay-Yagci E. YouTube as a source of information on fibromyalgia. Int J Rheum Dis. 2021 Feb;24(2):197-202.Texto completo Resumo
220. Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumatol. 2007 Mar;19(2):111-7. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal